IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF

IMMUTEP Ltd

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Oct 24, 2025

$3.17−0.03 (-0.94%)

Close on Oct 19, 2026

Dividends

Immutep has not reported a dividend

No dividend per share appears in Immutep's annual filings since fiscal 2015.

Where these numbers come from

Parsed from the XBRL in Immutep's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 28, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMMP.

Revenue growth31.8% · median -63.3%

Net margin-594.6% · median -4619.0%

Company	Revenue	Growth
PRQR	€15.91M	-15.9%
IMMP	A$10.33M	+31.8%
ALMS	$7.40M	–
NAMS	$7.12M	-88.9%
IMNM	$4.02M	-63.3%
PTCHF	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: June 30
Employees: 51
Auditor: PricewaterhouseCoopers
SEC CIK: 1506184

Advertisement
300 × 250